# Study Of Single Ascending Doses Of PBL 1427 In Healthy Volunteers

> **NCT01554293** · PHASE1 · UNKNOWN · sponsor: **Panacea Biotec Ltd** · enrollment: 48 (estimated)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Matching placebo
- **DRUG:** PBL 1427 capsules

## Key facts

- **NCT ID:** NCT01554293
- **Lead sponsor:** Panacea Biotec Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-07
- **Primary completion:** 2013-07
- **Final completion:** 2013-09
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2013-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01554293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01554293, "Study Of Single Ascending Doses Of PBL 1427 In Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01554293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*